Title |
Insights from the molecular docking and simulation analysis of seocalcitol with ACE2 and vitamin D receptor
|
Authors |
Sumanpreet Kaur1, Deepak Yadav1, Sukhpreet Singh1, Monu Kumari1, Deepak Kumar1, Kirtimaan Syal2, Rajasri Bhattacharyya1,* & Dibyajyoti Banerjee1,*
|
Affiliation |
1Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh- 160012, India; 2Department of Biological Sciences, Birla Institute of Technology and Science-Pilani, Hyderabad campus, Hyderabad, Telangana -500078, India; *Corresponding author
|
|
Sumanpreet Kaur - E-mail: sumankamboj436@gmail.com
|
Article Type |
Research Article
|
Date |
Received October 1, 2024; Revised November 5, 2024; Accepted November 5, 2024, Published November 5, 2024
|
Abstract |
COVID-19 has caused a severe impact on global health. Several studies have reported the use of Vitamin D in the management of COVID-19 illness; however, the molecular basis of its action is not clear. This draws an interest to understand the molecular insights of binding of vitamin D and its analogues with ACE2 (angiotensin-converting enzyme 2) and VDR (vitamin D receptor) using molecular docking analysis. Here, we have documented the molecular docking and simulation analysis of the binding interactions of seocalcitol with ACE2 and VDR for further consideration in managing COVID-19. |
Keywords |
Angiotensin converting enzyme 2 (ACE2); Vitamin D; Seocalcitol; COVID-19; molecular docking; vitamin D receptor (VDR).
|
Citation |
Kaur et al. Bioinformation 20(11): 1480-1482 (2024)
|
Edited by |
P Kangueane
|
ISSN |
0973-2063
|
Publisher |
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|